• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate.

作者信息

Silverdale Monty A, Kobylecki Christopher, Hallett Penelope J, Li Qin, Dunah Anthone W, Ravenscroft Paula, Bezard Erwan, Brotchie Jonathan M

机构信息

Greater Manchester Neurosciences Centre, Salford Royal Hospital, Stott Lane, Salford, United Kingdom.

出版信息

Synapse. 2010 Feb;64(2):177-80. doi: 10.1002/syn.20739.

DOI:10.1002/syn.20739
PMID:19852073
Abstract
摘要

相似文献

1
Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate.MPTP 损伤的非人类灵长类动物中左旋多巴诱导的异动症中 AMPA 谷氨酸受体亚基的突触募集
Synapse. 2010 Feb;64(2):177-80. doi: 10.1002/syn.20739.
2
Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.单侧丘脑底核切开术后运动障碍型帕金森病猴谷氨酸受体的变化
J Neurosurg. 2015 Dec;123(6):1383-93. doi: 10.3171/2014.10.JNS141570. Epub 2015 May 1.
3
Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia.在帕金森病和运动障碍的MPTP损伤猕猴模型中，纹状体AMPA受体结合未发生改变。
Exp Neurol. 2002 Mar;174(1):21-8. doi: 10.1006/exnr.2001.7854.
4
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.在帕金森病的MPTP损伤非人灵长类动物模型中，刺激大麻素受体可减轻左旋多巴诱导的运动障碍。
Mov Disord. 2002 Nov;17(6):1180-7. doi: 10.1002/mds.10289.
5
Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.非哌咪唑（JP-1730）是一种强效α2肾上腺素能受体拮抗剂，可减轻帕金森病MPTP损伤灵长类动物模型中左旋多巴诱导的运动障碍。
Mov Disord. 2003 Aug;18(8):872-83. doi: 10.1002/mds.10464.
6
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.神经元型一氧化氮合酶抑制可减轻半帕金森病大鼠左旋多巴诱导的运动障碍的发展。
Eur J Pharmacol. 2012 May 15;683(1-3):166-73. doi: 10.1016/j.ejphar.2012.03.008. Epub 2012 Mar 16.
7
Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.选择性阻断D(3)多巴胺受体可增强罗匹尼罗和左旋多巴对MPTP损伤灵长类动物的抗帕金森病特性。
Exp Neurol. 2004 Jul;188(1):128-38. doi: 10.1016/j.expneurol.2004.03.022.
8
Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.17β-雌二醇、孕酮和雷洛昔芬对MPTP处理的C57Bl/6小鼠的神经保护特性
Synapse. 2001 Aug;41(2):131-8. doi: 10.1002/syn.1067.
9
Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeys.硫酸镁对MPTP损伤猴子的抗运动障碍作用。
Exp Neurol. 2003 Aug;182(2):490-6. doi: 10.1016/s0014-4886(03)00125-0.
10
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys.谷氨酸拮抗剂可改善帕金森病猴的左旋多巴诱发的运动障碍。
Ann Neurol. 1996 May;39(5):574-8. doi: 10.1002/ana.410390505.

引用本文的文献

1
Unveiling differential gene co-expression networks and its effects on levodopa-induced dyskinesia.揭示差异基因共表达网络及其对左旋多巴诱导的异动症的影响。
iScience. 2024 Aug 26;27(9):110835. doi: 10.1016/j.isci.2024.110835. eCollection 2024 Sep 20.
2
Parkinson's disease, epilepsy, and amyotrophic lateral sclerosis-emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors.帕金森病、癫痫和肌萎缩侧索硬化——离子型谷氨酸受体的AMPA和海人藻酸亚型的新作用
Front Cell Dev Biol. 2023 Oct 24;11:1252953. doi: 10.3389/fcell.2023.1252953. eCollection 2023.
3
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients.
在 MPTP 损伤的猕猴黑质和帕金森病患者的脑脊液中，NMDA 受体共激动剂 D-丝氨酸的水平降低。
Sci Rep. 2019 Jun 20;9(1):8898. doi: 10.1038/s41598-019-45419-1.
4
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.左旋多巴诱导异动症中的神经炎症：超越免疫功能。
J Neural Transm (Vienna). 2018 Aug;125(8):1287-1297. doi: 10.1007/s00702-018-1874-4. Epub 2018 Mar 14.
5
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications.L-DOPA 诱导的运动障碍中的谷氨酸能机制及治疗意义。
J Neural Transm (Vienna). 2018 Aug;125(8):1225-1236. doi: 10.1007/s00702-018-1846-8. Epub 2018 Jan 31.
6
Serum sodium and chloride are inversely associated with dyskinesia in Parkinson's disease patients.血清钠和氯与帕金森病患者的运动障碍呈负相关。
Brain Behav. 2017 Nov 9;7(12):e00867. doi: 10.1002/brb3.867. eCollection 2017 Dec.
7
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.帕金森病中左旋多巴诱导的异动症的正电子发射断层扫描分子成像研究
Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2.
8
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.靶向β-抑制蛋白2治疗帕金森病左旋多巴诱导的异动症
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2517-26. doi: 10.1073/pnas.1502740112. Epub 2015 Apr 27.
9
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.治疗帕金森病患者左旋多巴诱导运动障碍的药物策略。
CNS Drugs. 2014 Dec;28(12):1155-84. doi: 10.1007/s40263-014-0205-z.
10
Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.脑形态计量学与左旋多巴诱导运动障碍的神经生物学：转化临床前神经影像学研究的现有知识和未来潜力。
Front Neurol. 2014 Jun 12;5:95. doi: 10.3389/fneur.2014.00095. eCollection 2014.